776 related articles for article (PubMed ID: 27068635)
21. Ecto-5'-nucleotidase deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction.
Xu X; Fassett J; Hu X; Zhu G; Lu Z; Li Y; Schnermann J; Bache RJ; Chen Y
Hypertension; 2008 Jun; 51(6):1557-64. PubMed ID: 18391093
[TBL] [Abstract][Full Text] [Related]
22. Ablation of cardiac TIGAR preserves myocardial energetics and cardiac function in the pressure overload heart failure model.
Okawa Y; Hoshino A; Ariyoshi M; Kaimoto S; Tateishi S; Ono K; Uchihashi M; Iwai-Kanai E; Matoba S
Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1366-H1377. PubMed ID: 30901275
[TBL] [Abstract][Full Text] [Related]
23. Local production of tenascin-C acts as a trigger for monocyte/macrophage recruitment that provokes cardiac dysfunction.
Abbadi D; Laroumanie F; Bizou M; Pozzo J; Daviaud D; Delage C; Calise D; Gaits-Iacovoni F; Dutaur M; Tortosa F; Renaud-Gabardos E; Douin-Echinard V; Prats AC; Roncalli J; Parini A; Pizzinat N
Cardiovasc Res; 2018 Jan; 114(1):123-137. PubMed ID: 29136112
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial Integrity and Function in the Progression of Early Pressure Overload-Induced Left Ventricular Remodeling.
Chaanine AH; Sreekumaran Nair K; Bergen RH; Klaus K; Guenzel AJ; Hajjar RJ; Redfield MM
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28619984
[TBL] [Abstract][Full Text] [Related]
25. BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery.
Merino D; Villar AV; García R; Tramullas M; Ruiz L; Ribas C; Cabezudo S; Nistal JF; Hurlé MA
Cardiovasc Res; 2016 Jun; 110(3):331-45. PubMed ID: 27068510
[TBL] [Abstract][Full Text] [Related]
26. Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin.
Lin H; Li Y; Zhu H; Wang Q; Chen Z; Chen L; Zhu Y; Zheng C; Wang Y; Liao W; Bin J; Kitakaze M; Liao Y
Cardiovasc Res; 2020 Jan; 116(1):101-113. PubMed ID: 30689763
[TBL] [Abstract][Full Text] [Related]
27. Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress.
Oudit GY; Kassiri Z; Zhou J; Liu QC; Liu PP; Backx PH; Dawood F; Crackower MA; Scholey JW; Penninger JM
Cardiovasc Res; 2008 Jun; 78(3):505-14. PubMed ID: 18281373
[TBL] [Abstract][Full Text] [Related]
28. T-cell recruitment to the heart: friendly guests or unwelcome visitors?
Blanton RM; Carrillo-Salinas FJ; Alcaide P
Am J Physiol Heart Circ Physiol; 2019 Jul; 317(1):H124-H140. PubMed ID: 31074651
[TBL] [Abstract][Full Text] [Related]
29. p53-Induced inflammation exacerbates cardiac dysfunction during pressure overload.
Yoshida Y; Shimizu I; Katsuumi G; Jiao S; Suda M; Hayashi Y; Minamino T
J Mol Cell Cardiol; 2015 Aug; 85():183-98. PubMed ID: 26055447
[TBL] [Abstract][Full Text] [Related]
30. Full Expression of Cardiomyopathy Is Partly Dependent on B-Cells: A Pathway That Involves Cytokine Activation, Immunoglobulin Deposition, and Activation of Apoptosis.
Cordero-Reyes AM; Youker KA; Trevino AR; Celis R; Hamilton DJ; Flores-Arredondo JH; Orrego CM; Bhimaraj A; Estep JD; Torre-Amione G
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26769625
[TBL] [Abstract][Full Text] [Related]
31. Ubiquitin ligase
Snyder LB; Lai Y; Doviak H; Freeburg LA; Laney VK; Moore A; Zellars KN; Matesic LE; Spinale FG
Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H976-H984. PubMed ID: 34559578
[TBL] [Abstract][Full Text] [Related]
32. Toll-like receptor 7 deficiency promotes survival and reduces adverse left ventricular remodelling after myocardial infarction.
de Kleijn DPV; Chong SY; Wang X; Yatim SMJM; Fairhurst AM; Vernooij F; Zharkova O; Chan MY; Foo RSY; Timmers L; Lam CSP; Wang JW
Cardiovasc Res; 2019 Oct; 115(12):1791-1803. PubMed ID: 30830156
[TBL] [Abstract][Full Text] [Related]
33. Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking.
Goldenberg JR; Carley AN; Ji R; Zhang X; Fasano M; Schulze PC; Lewandowski ED
Circulation; 2019 Jun; 139(24):2765-2777. PubMed ID: 30909726
[TBL] [Abstract][Full Text] [Related]
34. Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure.
Valiente-Alandi I; Potter SJ; Salvador AM; Schafer AE; Schips T; Carrillo-Salinas F; Gibson AM; Nieman ML; Perkins C; Sargent MA; Huo J; Lorenz JN; DeFalco T; Molkentin JD; Alcaide P; Blaxall BC
Circulation; 2018 Sep; 138(12):1236-1252. PubMed ID: 29653926
[TBL] [Abstract][Full Text] [Related]
35. Double-stranded RNA-dependent protein kinase deficiency protects the heart from systolic overload-induced congestive heart failure.
Wang H; Xu X; Fassett J; Kwak D; Liu X; Hu X; Falls TJ; Bell JC; Li H; Bitterman P; Bache RJ; Chen Y
Circulation; 2014 Apr; 129(13):1397-406. PubMed ID: 24463368
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.
Alex L; Russo I; Holoborodko V; Frangogiannis NG
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H934-H949. PubMed ID: 30004258
[TBL] [Abstract][Full Text] [Related]
37. The ATP-binding cassette transporter ABCG2 protects against pressure overload-induced cardiac hypertrophy and heart failure by promoting angiogenesis and antioxidant response.
Higashikuni Y; Sainz J; Nakamura K; Takaoka M; Enomoto S; Iwata H; Tanaka K; Sahara M; Hirata Y; Nagai R; Sata M
Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):654-61. PubMed ID: 22116099
[TBL] [Abstract][Full Text] [Related]
38. Myocardial remodeling with aortic stenosis and after aortic valve replacement: mechanisms and future prognostic implications.
Yarbrough WM; Mukherjee R; Ikonomidis JS; Zile MR; Spinale FG
J Thorac Cardiovasc Surg; 2012 Mar; 143(3):656-64. PubMed ID: 21762938
[TBL] [Abstract][Full Text] [Related]
39. Antagonizing the CX3CR1 Receptor Markedly Reduces Development of Cardiac Hypertrophy After Transverse Aortic Constriction in Mice.
Nemska S; Gassmann M; Bang ML; Frossard N; Tavakoli R
J Cardiovasc Pharmacol; 2021 Dec; 78(6):792-801. PubMed ID: 34882111
[TBL] [Abstract][Full Text] [Related]
40. Gut dysbiosis induced by cardiac pressure overload enhances adverse cardiac remodeling in a T cell-dependent manner.
Carrillo-Salinas FJ; Anastasiou M; Ngwenyama N; Kaur K; Tai A; Smolgovsky SA; Jetton D; Aronovitz M; Alcaide P
Gut Microbes; 2020 Nov; 12(1):1-20. PubMed ID: 33103561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
